+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Hematological Malignancies Drug"

Global Hematological Malignancies Market by Types (Leukemia, Lymphoma, Multiple Myeloma), Treatment (Bone Marrow Transplantation, Chemotherapy, Chimeric Antigen Receptor (Car) T Cell Therapy), Diagnosis, End-Users - Forecast 2024-2030 - Product Thumbnail Image

Global Hematological Malignancies Market by Types (Leukemia, Lymphoma, Multiple Myeloma), Treatment (Bone Marrow Transplantation, Chemotherapy, Chimeric Antigen Receptor (Car) T Cell Therapy), Diagnosis, End-Users - Forecast 2024-2030

  • Report
  • March 2024
  • 199 Pages
  • Global
From
Hematological Malignancies: Global Strategic Business Report - Product Thumbnail Image

Hematological Malignancies: Global Strategic Business Report

  • Report
  • April 2024
  • 193 Pages
  • Global
From
Global Hematologic Malignancies Treatment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Thumbnail Image

Global Hematologic Malignancies Treatment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • February 2024
  • 111 Pages
  • Global
From
Hematological Malignancies Emerging Therapeutics Market - A Global and Regional Analysis: Focus on Therapeutic Type (Marketed), Potential Pipeline Products, Indication, and Region - Analysis and Forecast, 2021-2031 - Product Thumbnail Image

Hematological Malignancies Emerging Therapeutics Market - A Global and Regional Analysis: Focus on Therapeutic Type (Marketed), Potential Pipeline Products, Indication, and Region - Analysis and Forecast, 2021-2031

  • Report
  • February 2022
  • 258 Pages
  • Global
From
Hematological Malignancies Disease Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Hematological Malignancies Disease Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • June 2023
  • 110 Pages
  • Global
From
Hematological Malignancies Market - Forecast (2022 - 2027) - Product Thumbnail Image

Hematological Malignancies Market - Forecast (2022 - 2027)

  • Report
  • February 2022
  • 100 Pages
  • Global
From
  • 6 Results (Page 1 of 1)
Loading Indicator

The Hematological Malignancies Drug market is a subset of the pharmaceutical industry that focuses on the development and production of drugs used to treat leukemia and other blood-related cancers. These drugs are used to treat a variety of conditions, including acute myeloid leukemia, chronic myeloid leukemia, acute lymphoblastic leukemia, and chronic lymphocytic leukemia. The drugs are typically administered intravenously or orally, and may be used in combination with other treatments such as chemotherapy or radiation therapy. The Hematological Malignancies Drug market is highly competitive, with many companies vying for market share. Some of the major players in the market include Novartis, Celgene, Pfizer, Bristol-Myers Squibb, and Merck. Other companies in the market include AbbVie, AstraZeneca, Johnson & Johnson, and Roche. Show Less Read more